4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000072
EVP Research sold 9,933 shares at an average $75.34 ($748,383)
- EVP Research acquired 21,477 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Swayze Eric · EVP Research
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-15 | Exercise or conversion : show line 1 in the form | +21,366 | 51,819 | D | ||
| 2026-01-16 | Sale : show line 2 in the form | −9,884 | $75.34 | $744,661 | 41,935 | D |
| 2026-01-15 | Exercise or conversion : show line 3 in the form | +111 | 367 | I | ||
| 2026-01-16 | Sale : show line 4 in the form | −49 | $75.97 | $3,723 | 318 | I |
| Open-market sales · 9,933 sh · avg $75.34 · $748,383 | ||||||
Table II: Derivative
5 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-15 | Grant or award : show line 5 in the form Performance Restricted Stock Units | +25,800 | 90,282 | D |
| 2026-01-15 | Exercise or conversion : show line 6 in the form Restricted Stock Unit | −21,366 | 39,251 | D |
| 2026-01-15 | Grant or award : show line 7 in the form Restricted Stock Unit | +9,675 | 48,926 | D |
| 2026-01-15 | Exercise or conversion : show line 8 in the form Restricted Stock Unit | −111 | 386 | I |
| 2026-01-15 | Grant or award : show line 9 in the form Restricted Stock Unit | +225 | 611 | I |
Loading xslF345X05/edgardoc.xml…